Pressões respiratórias máximas em indivíduos obesos antes e após cirurgia bariátrica / Maximum respiratory pressure in obese individuals before and after bariatric surgery

A obesidade é uma doença crônica e multifatorial que leva a alterações sistêmicas e é considerada um problema de saúde pública mundial. Entre as alterações respiratórias decorrentes da obesidade se discute como o ganho de peso ou a perda deste pode interferir nas pressões respiratórias máximas (PRM), não existindo consenso na literatura. Objetivo: Analisar o poder preditivo das equações de referência para PMR em obesos antes e após perda de peso. Métodos: Estudo transversal no qual foram incluídos vinte pacientes obesos dos Programas de Cirurgia Bariátrica de hospitais de referência em Manaus/Amazonas, que tiveram as PRM avaliadas por meio de manuvacuometria antes e aproximadamente um ano e meio após a cirurgia bariátrica. Resultados: O peso médio diminuiu de 138,5 ± 21,7 kg para 82,7 ± 8,2 kg após a cirurgia. As PRM foram supranormais antes da cirurgia e reduzidas após a cirurgia. Entre as equações analisadas, apenas as propostas por Sanchez et al. foram capazes de predizer os valores medidos. Conclusão: As PRM foram aumentadas nos obesos mórbidos avaliados e reduzidas após a cirurgia. As equações mais utilizadas na prática clínica brasileira parecem não ser capazes de predizer valores de PRM nessa população, sendo as mais adequadas as propostas por Sanchez et al. (AU)

Obesity is a chronic and multifactorial disease and is considered a global public health problem. Among the respiratory changes due to obesity, weight gain or loss of body weight can interfere with maximal respiratory pressures, and there is no consensus in the literature. Objective: To analyze the predictive power of the reference equations for maximal respiratory pressures in obese before and after weight loss. Methods: A crosssectional study was carried out in which 20 obese patients were included in the Bariatric Surgery Programs of reference hospitals in Manaus/Amazonas. The maximal respiratory pressures were assessed by manuvacuometry before and approximately one year after bariatric surgery. Results: The mean weight decreased from 138.5 ± 21.7 kg to 82.7 ± 8.2 kg after surgery. The maximal respiratory pressures were supranormal before surgery and reduced after surgery. Among the analyzed equations, only those proposed by Sanchez et al. were able to predict the measured values. Conclusion: The maximal respiratory pressures were increased in the morbidly obese evaluated and reduced after the surgery. The most used equations in Brazilian clinical practice seem not to be able to predict maximal respiratory pressures values in this population, being the most adequate those proposed by Sanchez et al. (AU)

Predictive equations for respiratory muscle strength by anthropometric variables.

Recent studies have pointed out divergences in the predictive quality of reference equations for respiratory muscle strength, alerting the need to introduce into these equation-specific variables for certain target populations. OBJECTIVES: This study proposes predictive equations of respiratory muscle strength by the variables such as body weight and body mass index (BMI = weight/height2 ). MATERIALS AND METHODS: This is a cross-sectional study, and the evaluation was made by the test of maximum static respiratory pressures (MIP and MEP) according to standard protocol of the Brazilian Society of Pneumology and Tisiology. For data analysis, the following three models of linear regression were adjusted: age, age/weight, age/BMI. The software used in the analysis was the R version 3.2.1. RESULTS: Of the 353 subjects evaluated (229 women and 124 men), 109 subjects were normal weight, 101 subjects were overweight and 143 subjects were obese. The BMI average of the individuals was 31.42 ± 10.26 kg/m2 and age 46.26 ± 16.47 years. The two statistical models that considered the variables weight and BMI had the R2 value of 29.86% for MEP and 21.77% for MIP when the weight was the predictive variable and 21.33% for MIP and 28.38% for MEP when the variable was BMI. CONCLUSION: It was found with the adjusted models that there was a considerable gain in the predictive quality of the models for MEP and MIP adding weight or BMI, without significant difference between both.

Determinação do risco cardiovascular em adultos jovens universitários / Determination of cardiovascular risk in young adults university students

O objetivo deste estudo foi determinar o risco cardiovascular em uma população de adultos jovens universitários que frequentam os cursos de Educação Física e Fisioterapia na Universidade Federal do Amazonas utilizando o Escore de Framingham e o Escore de Risco Global. Trata-se de um estudo observacional transversal onde foram avaliados 63 indivíduos de ambos os sexos com 20-30 anos. Os métodos de avaliação incluíram questionário, análise antropométrica e coleta sanguínea para realização dos exames bioquímicos. Para determinação do risco cardiovascular foram utilizados os escores de Framingham (ERF) e Risco Global (ERG) para uma idade modificada de 65 anos. As análises estatísticas foram descritivas (média, desvio-padrão, frequência simples e percentagem). O Teste t de Student foi aplicado para comparação entre grupos (p<0,05). O ERF identificou, entre o sexo masculino 23,53% com baixo risco e 76,47% com risco intermediário para desenvolvimento de doença cardiovascular nos próximos 10 anos. Todas as mulheres apresentaram baixo risco. O ERG demonstrou que entre os homens, 94,12% apresentaram risco intermediário e 5,88% alto risco, e dentre as mulheres 63,04% estavam na faixa de baixo risco e 36,96% risco intermediário. Os resultados demonstram a ocorrência de níveis intermediários no desenvolvimento de DCV na população de adultos jovens nos próximos 10 anos figurando-os como alvo imediato de ações preventivas.

The objective of this study was to determine the cardiovascular risk in a population of young university students attending the courses of Physical Education and Physiotherapy at the Federal University of Amazonas using the Framingham Score and the Global Risk Score. It is a cross-sectional observational study in which 63 individuals of both sexes with 20-30 years were evaluated. Methods of evaluation included questionnaire, anthropometric analysis and blood collection for biochemical tests. The Framingham (FRE) and Global Risk (GRE) scores for a modified age of 65 years were used to determine cardiovascular risk. Statistical analyzes were descriptive (mean, standard deviation, simple frequency and percentage). Student's t-test was applied for comparison between groups (p <0.05). The FRE identified 23.53% of men with low risk and 76.47% with intermediate risk for cardiovascular disease in the next 10 years. All women were at low risk. The GRE showed that among the men, 94.12% presented intermediate risk and 5.88% high risk, and among the women 63.04% were in the low risk range and 36.96% intermediate risk. The results demonstrate the occurrence of intermediate levels in the development of CVD in the population of young adults in the next 10 years, as an immediate target for preventive actions.

Reabilitação pulmonar em indivíduos com fibrose pulmonar idiopática: qual a evidência? / Pulmonary rehabilitation in individuals with idiopathic pulmonary fibrosis: what is the evidence?

Introdução: A fibrose pulmonar idiopática (FPI) é uma pneumonia intersticial idiopática crônica, progressiva, sem cura, com morte entre 3 meses a 4 anos após o diagnóstico. A qualidade de vida (QV) dos indivíduos com FPI é baixa, com muitos sintomas respiratórios. Têm-se demonstrado que a melhora da QV e dos sintomas pode ocorrer com a reabilitação pulmonar (RP). Contudo, existem poucos estudos nacionais sobre o assunto sendo esta conduta pouca realizada no Brasil. Objetivos: Investigar evidências científicas sobre a RP em indivíduos com FPI. Métodos: Revisão sistemática de estudos secundários: diretrizes, guidelines e revisões sistemáticas, em inglês e português, publicados entre 2000 e 2016 nas bases de dados: BVS, Cochrane Library, PEDro, PubMed, Scielo Org. Os descritores e seus correlatos foram identificados no Medical Subject Headings e nos Descritores em Ciências da Saúde. A questão PICO foi: P: indivíduo com FPI, I: reabilitação pulmonar, O: tempo livre de piora, dispneia, distância percorrida no teste de caminhada de 6 minutos, saturação periférica de oxigênio (SpO2), QV, capacidade vital forçada (CVF) e sobrevida. A qualidade metodológica foi avaliada através do Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) e do Revised Assessment of Multiple Systematic Reviews (R-AMSTAR). O grau de recomendação e a sugestão da prática foram baseados no United States Preventive Services Task Force (USPSTF). Resultados: Seis artigos foram incluídos com boa qualidade metodológica. A RP foi recomendada para a maioria dos indivíduos com FPI ­ grau de recomendação B. Conclusão: A RP foi capaz de melhorar positivamente a maioria dos desfechos analisados, devendo ser incluída no rol de condutas terapêuticas para indivíduos com FPI que desejarem realiza-la. (AU)

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and idiopathic interstitial pneumonia, uncured, with fatal issue in 3 months to 4 years after diagnosis. Quality of life (QOL) of patients with IPF is weak, with many respiratory symptoms. Improving QOL and symptoms can occur with pulmonary rehabilitation (PR). However, there are few national studies on the subject and this rehabilitation has little place in Brazil. Objectives: To investigate scientific evidence available on the RP in patients with IPF. Methods: Systematic review of secondary studies: policies, guidelines and systematic reviews in English and Portuguese, published between 2000 and 2016 in the data bases: BVS, Cochrane Library, PEDro, PubMed, Scielo Org. Descriptors and their specific correlates were identified in the Medical Subject Headings (MESH) and the Descriptors in Health Sciences (DECS). The question PICO was: P: individual with IPF, I: pulmonary rehabilitation, O: outcome: worsening of free time, dyspnea, distance walked in 6-minute walk test, oxygen saturation (SpO2), QOL, forced vital capacity (FVC) and survival. Methodological quality was assessed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Revised Assessment of Multiple Systematic Reviews (R-AMSTAR). The degree of recommendation and practical suggestions were based on the United States Preventive Services Task Force (USPSTF). Results: Six articles were included with good methodological quality. The RP is recommended for most individuals with IPF - degree of recommendation B. Conclusion: The RP was able to positively improve most of the outcomes and should be included in the list of therapeutic approaches for individuals with IPF who want to achieve it.(AU)

Aspiração endotraqueal de adultos intubados: evidências para boas práticas / Endotracheal suctioning of the adults intubated: evidence for best practice

Introdução: A aspiração endotraqueal é o procedimento invasivo mais realizado em indivíduos intubados em unidades de terapia intensiva. Contudo, existem poucos estudos nacionais de boa qualidade metodológica sobre o assunto, não havendo no Brasil consenso da literatura e/ou padronização da técnica. Objetivos: Estabelecer recomendações baseadas em evidências científicas sobre a aspiração endotraqueal em adultos intubados. Métodos: Revisão sistemática de estudos secundários: diretrizes, guidelines e revisões sistemáticas em inglês e português, pesquisada nas bases de dados PubMed, Cochrane, Cochrane Review, Cochrane Library, Scielo Org, Scielo Brasil, PEDro, Clinical Evidence e Evidence Based Medicine. Resultados: Foram incluídos cinco artigos com classificação entre C e D pelo R-Amstar. Conclusão: A aspiração endotraqueal deve ser realizada em adultos intubados por pessoal qualificado, assepticamente, sempre que necessária. Não deve exceder 15 segundos por aspiração e nem ser realizada rotineiramente, e sim, na presença de secreções ­ grau de recomendação A. A sonda de aspiração deve ter um diâmetro menor que 50% do tubo endotraqueal e a hiperoxigenação com fração inspirada de oxigênio a 100% no ventilador deve ser utilizada ­ grau de recomendação A. A pressão de sucção não deve exceder 150 mmHg negativos ­ grau de recomendação B. É recomendada a aspiração subglótica, especialmente naqueles indivíduos com mais de 72 horas de ventilação mecânica invasiva ­ grau de recomendação A. (AU)

Introduction: Endotracheal aspiration is the most accomplished invasive procedure in intubated individuals in intensive care units. However, there are few national studies of good methodological quality on the subject, and there is no consensus in the literature and / or standardization of the technique. Aims: To establish recommendations based on scientific evidence on endotracheal aspiration in intubated adults. Methods: Systematic review of secondary studies: guidelines, guidelines and systematic reviews in English and Portuguese, searched in the databases PubMed, Cochrane, Cochrane Review, Cochrane Library, Scielo Org, Scielo Brazil, PEDro, Clinical Evidence and Evidence Based Medicine. Results: Five articles with classification between C and D by R-Amstar were included. Conclusion: Endotracheal aspiration should be performed in adults intubated by qualified personnel, aseptically, whenever necessary. It should not exceed 15 seconds per aspiration and should not be performed routinely, but in the presence of secretions - degree of recommendation A. The aspiration probe should have a diameter of less than 50% of the endotracheal tube and hyperoxigenation with inspired fraction of oxygen at 100% in the ventilator should be used - degree of recommendation A. The suction pressure should not exceed 150 mmHg negative - degree of recommendation B. Subglottic aspiration is recommended, especially in those individuals with more than 72 hours of invasive mechanical ventilation - degree of Recommendation A. (AU)

BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.

BACKGROUND: The body mass index/airflow obstruction/dyspnea/exercise capacity (BODE) index and global initiative for chronic obstructive lung disease (GOLD) staging system are validated measures to define disease severity and to predict survival in chronic obstructive pulmonary disease (COPD). We aimed to investigate the influence of BODE classes (score: 0-2, 3-4, 5-7, and 7-10) and GOLD stages (I, II, III, and IV) on the moderate/severe exacerbation occurrence risk in a cohort of 120 mild/very severe stable patients with COPD. METHODS: Demographics, clinical evaluation, spirometry, peripheral oxygen saturation, body composition, 6-minute walking distance, dyspnea, and quality of life measurements were obtained at baseline. Patients were followed up for 1 year or until death, and information on exacerbation was collected. RESULTS: The median annual exacerbation rate was 0.8. Logistic regression showed that the relationship between the risk for moderate/severe exacerbations during a 1-year follow-up for the GOLD stage was odds ratio: 2.01; 95% confidence interval: 1.39-2.98 and for the BODE index was odds ratio: 2.08; 95% confidence interval: 1.27-3.61. The area under the receiver-operator curve to predict exacerbation during the 1-year follow-up was 0.69 for the GOLD stage and 0.62 for the BODE index. Adjusted multiple logistic regression selected only older age and lower peripheral oxygen saturation as risk factors for COPD exacerbation in the 1-year follow-up. CONCLUSIONS: In summary, our study shows that unidimensional GOLD classification and multidimensional BODE index staging systems seem to have similar clinical utility in predicting exacerbation in ambulatory COPD patients with COPD. However, variables not included in both systems seem to be the main predictors of the exacerbation risk.

Influence of lean body mass on cardiopulmonary repercussions during the six-minute walk test in patients with COPD.

OBJECTIVE: Although lean body mass (LBM) has been associated with mortality in patients with COPD, its influence on functional limitation is not clear. The objective of this study was to analyze the cardiopulmonary variables in COPD patients with or without LBM depletion, prior to and after the six-minute walk test (6MWT). METHODS: We evaluated COPD patients, 32 with LBM depletion and 36 without. All patients underwent clinical evaluation, spirometry, evaluation of body mass composition and 6MWT, as well as completing questionnaires related to quality of life and perception of dyspnea. RESULTS: No significant differences in the severity of airway obstruction, perception of dyspnea and quality of life scores were found between the groups. The distance covered on the 6MWT was similar in COPD patients with and without LBM depletion (470.3 +/- 68.5 m vs. 448.2 +/- 89.2 m). However, patients with LBM depletion presented significantly greater differences between baseline and final values in terms of heart rate and Borg scale index for lower limb fatigue. There was a significant positive correlation between distance covered on the 6MWT and FEV1 (r = 0.381, p = 0.01). CONCLUSIONS: In the patients studied, functional exercise tolerance and quality of life were unaffected by LBM depletion. However, the patients with LBM depletion presented more pronounced lower limb fatigue during the 6MWT, which underscores the importance of the evaluation and treatment of systemic manifestations in COPD patients.

Influência da massa magra corporal nas repercussões cardiopulmonares durante o teste de caminhada de seis minutos em pacientes com DPOC / Influence of lean body mass on cardiopulmonary repercussions during the six-minute walk test in patients with COPD

OBJETIVO: A massa magra corporal (MMC) tem sido associada à mortalidade em pacientes com DPOC, mas seu impacto na limitação funcional é pouco conhecido. O objetivo deste trabalho foi analisar as variáveis cardiopulmonares em pacientes com DPOC, com ou sem depleção da MMC, antes e após a realização do teste de caminhada de seis minutos (TC6). MÉTODOS: Foram avaliados pacientes com DPOC, 36 sem depleção de MMC e 32 com depleção de MMC. Todos os pacientes foram submetidos à avaliação clínica, espirometria, avaliação da composição da massa corpórea e TC6 e responderam a questionários de qualidade de vida e de percepção de dispnéia. RESULTADOS: Não foram observadas diferenças significativas na gravidade de obstrução das vias aéreas, na percepção da dispnéia e na qualidade de vida entre os grupos. A distância percorrida no TC6 foi similar nos pacientes com DPOC com e sem depleção de MMC (470,3 ± 68,5 m vs. 448,2 ± 89,2 m). Entretanto, durante a realização do teste, os pacientes com depleção de MMC apresentaram aumento significativamente maior na diferença entre os valores final e basal da frequência cardíaca e do índice da escala de Borg para cansaço dos membros inferiores. A distância percorrida no TC6 apresentou correlação significativa positiva com o VEF1 (r = 0,381; p = 0,01). CONCLUSÕES: Não houve influência da depleção da MMC na capacidade funcional de exercício e na qualidade de vida dos pacientes estudados. Entretanto, os pacientes com depleção de MMC apresentam sintomas de fadiga dos membros inferiores mais acentuados durante o TC6, o que reforça a importância da avaliação e tratamento das manifestações sistêmicas da DPOC.

OBJECTIVE: Although lean body mass (LBM) has been associated with mortality in patients with COPD, its influence on functional limitation is not clear. The objective of this study was to analyze the cardiopulmonary variables in COPD patients with or without LBM depletion, prior to and after the six-minute walk test (6MWT). METHODS: We evaluated COPD patients, 32 with LBM depletion and 36 without. All patients underwent clinical evaluation, spirometry, evaluation of body mass composition and 6MWT, as well as completing questionnaires related to quality of life and perception of dyspnea. RESULTS: No significant differences in the severity of airway obstruction, perception of dyspnea and quality of life scores were found between the groups. The distance covered on the 6MWT was similar in COPD patients with and without LBM depletion (470.3 ± 68.5 m vs. 448.2 ± 89.2 m). However, patients with LBM depletion presented significantly greater differences between baseline and final values in terms of heart rate and Borg scale index for lower limb fatigue. There was a significant positive correlation between distance covered on the 6MWT and FEV1 (r = 0.381, p = 0.01). CONCLUSIONS: In the patients studied, functional exercise tolerance and quality of life were unaffected by LBM depletion. However, the patients with LBM depletion presented more pronounced lower limb fatigue during the 6MWT, which underscores the importance of the evaluation and treatment of systemic manifestations in COPD patients.

Relação entre o índice de massa corporal e a gravidade da asma em adultos / Relationship between body mass index and asthma severity in adults

OBJETIVO: O aumento do índice de massa corporal (IMC) tem sido associado a uma maior prevalência da asma em adultos. O presente estudo tem o objetivo de avaliar a associação entre a prevalência da obesidade e a gravidade da asma. MÉTODOS: Prontuários de duzentos asmáticos acima dos 20 anos de idade foram avaliados retrospectivamente. A asma foi classificada quanto à gravidade através da história clínica e do diagnóstico registrados, dos resultados da espirometria e da medicação prescrita. O IMC foi calculado e foram considerados obesos os pacientes com IMC > 30 kg/m². RESULTADOS: 23 por cento dos pacientes apresentavam asma intermitente, 25,5 por cento, asma persistente leve, 24 por cento, asma persistente moderada e 27,5 por cento, asma persistente grave. O IMC < 29,9 kg/m² foi observado em 68 por cento dos pacientes e em 32 por cento o IMC foi > 30 kg/m². O odds ratio da relação entre a obesidade e a gravidade da asma foi de 1,17 (CI95 por cento: 0,90-1,53; p > 0,05). CONCLUSÕES: Na amostra estudada não foi encontrada correlação entre a obesidade e a gravidade da asma nem no sexo masculino, nem no feminino.

OBJECTIVE: Elevated values of body mass index (BMI) have been associated with higher prevalence of asthma in adults. The aim of the present study is to evaluate the association between obesity and asthma severity. METHODS: Medical records of two hundred patients older than 20 years of age were evaluated retrospectively. Asthma severity was established after the evaluation of the medical history and diagnosis recorded, spirometry results and the medicines prescribed. BMI was calculated and patients were classified as obese when the BMI was > 30 kg/m². RESULTS: 23 percent of the patients presented intermittent asthma, 25.5 percent presented mild persistent asthma, 24 percent presented moderate persistent asthma, and 27.5 percent presented severe persistent asthma. Values of BMI < 29.9 kg/m² were observed in 68 percent of the patients and in 32 percent the BMI was > 30 kg/m². The odds ratio of the correlation between obesity and asthma severity was 1.17 (95 percent CI: 0.90-1.53; p > 0.05). CONCLUSIONS: In the sample evaluated in this study no correlation between obesity and asthma severity was found for either gender.

[Relationship between body mass index and asthma severity in adults]. / Relação entre o índice de massa corporal e a gravidade da asma em adultos.

OBJECTIVE: Elevated values of body mass index (BMI) have been associated with higher prevalence of asthma in adults. The aim of the present study is to evaluate the association between obesity and asthma severity. METHODS: Medical records of two hundred patients older than 20 years of age were evaluated retrospectively. Asthma severity was established after the evaluation of the medical history and diagnosis recorded, spirometry results and the medicines prescribed. BMI was calculated and patients were classified as obese when the BMI was > 30 kg/m(2). RESULTS: 23% of the patients presented intermittent asthma, 25.5% presented mild persistent asthma, 24% presented moderate persistent asthma, and 27.5% presented severe persistent asthma. Values of BMI < or = 29.9 kg/m(2) were observed in 68% of the patients and in 32% the BMI was > or = 30 kg/m(2). The odds ratio of the correlation between obesity and asthma severity was 1.17 (95% CI: 0.90-1.53; p > 0.05). CONCLUSIONS: In the sample evaluated in this study no correlation between obesity and asthma severity was found for either gender.

Função e massa muscular em pacientes com doença pulmonar obstrutiva crônica / Function and muscle mass in patients with chronic obstructive pulmonary disease

A doença pulmonar obstrutiva crônica (DPOC) apresenta manifestações sistêmicas e, dentre entre elas, as alterações nutricionais são bastante evidentes. A perda de peso e o índice de massa do corpo (IMC) foram os primeiros indicadores do estado nutricional relacionados ao prognóstico em pacientes com DPOC. Entretanto, estudos recentes ressaltam a maior prevalência da depleção da massa magra do corpo (MMC) nestes pacientes. Embora algumas repercussões da depleção da MMC em pacientes com DPOC sejam conhecidas, as informações sobre a distribuição, mecanismos e características das alterações parecem contraditórios. Alguns estudos sustentam a idéia de que a fraqueza muscular é proporcional à perda de massa muscular. Por outro lado, os resultados de estudos recentes sugerem que as alterações qualitativas ou funcionais são mecanismos, adicionais à atrofia, envolvidos na disfunção muscular de pacientes com DPOC. Outro aspecto contraditório é o envolvimento de diferentes grupos musculares; alguns estudos mostram que a função dos músculos dos membros superiores (MMSS) encontra-se relativamente preservada enquanto outros sugerem a existência de fraqueza muscular generalizada. O impacto da disfunção muscular na endurance e na tolerância ao exercício também é controverso. Os objetivos deste estudo foram avaliar a prevalência e as repercussões da depleção da massa muscular sistêmica e localizada em pacientes com DPOC. Foram avaliados sessenta e dois pacientes com DPOC atendidos no Ambulatório de Pneumologia da Faculdade de Medicina de Botucatu - UNESP; vinte e seis pacientes (VEF1: 49,0 mais ou menos 18,0%) com depleção de MMC e trinta e seis pacientes (VEF1: 59,8 mais ou menos 24,4%) sem depleção de MMC. A depleção foi caracterizada pela presença de índice de MMC (IMMC) menor que 15 kg/m2, para mulheres, e menor que 16 kg/m2, para homens.

Manifestações sistêmicas na doença pulmonar obstrutiva crônica / Systemic manifestations in chronic obstructive pulmonary disease

A doença pulmonar obstrutiva crônica é progressiva e está relacionada a uma resposta inflamatória anormal dos pulmões à inalação de partículas e/ou gases tóxicos, sobretudo a fumaça de cigarro. Embora acometa primariamente os pulmões, diversas manifestações extrapulmonares relacionadas a esta enfermidade têm sido descritas. O aumento do número de células inflamatórias, que resulta em produção anormal de citocinas pró-inflamatórias, e o desequilíbrio entre a formação de radicais livres e a capacidade antioxidante, resultando em sobrecarga oxidativa, provavelmente são mecanismos envolvidos na inflamação local e sistêmica. Além disso, a diminuição do condicionamento físico secundária às limitações ventilatórias pode estar envolvida no desenvolvimento de alterações musculares. A doença pulmonar obstrutiva crônica apresenta diversas manifestações sistêmicas que incluem a depleção nutricional, a disfunção dos músculos esqueléticos, que contribui para a intolerância ao exercício, e as manifestações relacionadas a co-morbidades comumente observadas nestes pacientes. Essas manifestações têm sido relacionadas à sobrevida e ao estado geral de saúde dos pacientes. Nesse sentido, esta revisão tem como objetivo discutir os achados da literatura relacionados às manifestações sistêmicas da doença pulmonar obstrutiva crônica, ressaltando o papel da inflação sistêmica, e algumas perspectivas de tratamento.

Systemic manifestations in chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease is progressive and is characterized by abnormal inflammation of the lungs in response to inhalation of noxious particles or toxic gases, especially cigarette smoke. Although this infirmity primarily affects the lungs, diverse extrapulmonary manifestations have been described. The likely mechanisms involved in the local and systemic inflammation seen in this disease include an increase in the number of inflammatory cells (resulting in abnormal production of inflammatory cytokines) and an imbalance between the formation of reactive oxygen species and antioxidant capacity (leading to oxidative stress). Weakened physical condition secondary to airflow limitation can also lead to the development of altered muscle function. Chronic obstructive pulmonary disease presents diverse systemic effects including nutritional depletion and musculoskeletal dysfunction (causing a reduction in exercise tolerance), as well as other effects related to the comorbidities generally observed in these patients. These manifestations have been correlated with survival and overall health status in chronic obstructive pulmonary disease patients. In view of these facts, the aim of this review was to discuss findings in the literature related to the systemic manifestations of chronic obstructive pulmonary disease, emphasizing the role played by systemic inflammation and evaluating various therapeutic strategies.